Log in to search using one of your social media accounts:

 

PFO Closure Reduces Strokes, and PPIs Increase Dementia Risk? PFO Closure Reduces Strokes, and PPIs Increase Dementia Risk?
New research suggests that reducing patent foramen ovale size could lessen stroke risk, while other work explores the role that PPIs might play in causing dementia.Medscape Neurology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - October 17, 2017 Category: Consumer Health News Tags: Neurology & Neurosurgery Commentary Source Type: news

Data Boosts Support for Abbott, Gore PFO Closure Tech
Devices designed to lower a patient's stroke risk by surgically closing a hole in the heart known as a patent foramen ovale, have historically had a tough time in clinical trials. Data from three separate studies published in the New England Journal of Medicine could go a long way toward boosting support two market-leading PFO closure devices, but figuring out who should have the procedure and who should not continues to be a gray area for clinicians and patients. Long-term results from the RESPECT trial, which evaluated the Amplatzer device that Abbott acquired when it bought St. Jude Medical, along with new dat...
Source: MDDI - September 15, 2017 Category: Medical Devices Authors: Amanda Pedersen Tags: MD & M Minneapolis R Medical Device Business Source Type: news

Landmark Study Published in the New England Journal of Medicine Shows Abbott's AMPLATZER ™ Device Significantly Reduces Risk of Recurrent Stroke for People Living with a Hole in their Heart
-One in four people live with a small opening between the upper left and right chambers of the heart, called a patent foramen ovale (PFO), that increases their risk for recurrent stroke (Source: Abbott.com)
Source: Abbott.com - September 14, 2017 Category: Pharmaceuticals Source Type: news

Device used to close small hole in heart may protect against recurrent stroke
A device used to close a small hole in the heart may benefit certain stroke patients by providing an extra layer of protection for those facing years of ongoing stroke risk, according to the results of a large clinical trial led by UCLA researchers.“It is a major new treatment option for some people,” said Dr. Jeffrey Saver, director of theUCLA Comprehensive Stroke Center and lead author of the study. However, he added, “Using the device is going to have to be a considered clinical decision between the doctor and the patient about who’s the right person to get it.”Thefindings appear in the Sep...
Source: UCLA Newsroom: Health Sciences - September 14, 2017 Category: Universities & Medical Training Source Type: news

PFO Closure Reduces Stroke Recurrence PFO Closure Reduces Stroke Recurrence
Three new studies provide evidence that closure of patent foramen ovale in select patients after stroke reduced the stroke recurrence rate compared with medical therapy.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - September 13, 2017 Category: Consumer Health News Tags: Neurology & Neurosurgery News Source Type: news

ESOC 2017 Roundup: Gore touts lowered ischemic stroke, new brain infarcts in PFO Occluder test
W.L. Gore & Associates yesterday released results from the Reduce study of its Cardioform Septal Occluder devices used to close patent foramen ovale, touting a reduction in recurrent ischemic strokes and new brain infarcts. The Gore Cardioform Septal Occluder is designed to be inserted via catheter and is currently cleared by the FDA for closure of atrial septal defects. “It is of the utmost importance to us to be transparent and share clinical data as quickly as possible. We completed our two-year primary endpoint follow-up with patients in March and have worked diligently to release these important data to the ...
Source: Mass Device - May 17, 2017 Category: Medical Devices Authors: Fink Densford Tags: Cardiac Implants Cardiovascular Catheters Clinical Trials Stryker W.L. Gore & Associates Source Type: news

Finally, Success Reducing Recurrent Stroke With PFO Closure Finally, Success Reducing Recurrent Stroke With PFO Closure
Two new clinical trials showing a reduction in recurrent strokes with the closure of a patent foramen ovale (PFO) look set to change clinical practice.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - May 17, 2017 Category: Consumer Health News Tags: Neurology & Neurosurgery News Source Type: news

PFO closure is more effective than medical management in preventing recurrent stroke, long-term study results show
Percutaneously closing a patent foramen ovale (PFO) using the Amplatzer PFO Occluder was superior to medical management in the prevention of recurrent ischemic stroke in patients who previously had a cryptogenic stroke, final results from the RESPECT trial found. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - November 1, 2016 Category: Science Source Type: news

Final results from the RESPECT study reported at TCT 2016
(Cardiovascular Research Foundation) Final results from the RESPECT trial found that percutaneously closing a patent foramen ovale (PFO) using the Amplatzer PFO Occluder was superior to medical management in the prevention of recurrent ischemic stroke in patients who previously had a cryptogenic stroke. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - November 1, 2016 Category: Global & Universal Source Type: news

FDA Approves First PFO Occlusion Device to Prevent Recurrent Stroke (FREE)
By Amy Orciari Herman Edited by Susan Sadoughi, MD, and Andr é Sofair, MD, MPH The FDA on Friday approved a patent foramen ovale (PFO) occlusion device to help prevent recurrent stroke in patients with a PFO who've had an … (Source: Physician's First Watch current issue)
Source: Physician's First Watch current issue - October 30, 2016 Category: Primary Care Source Type: news

HeartStitch(R) Presence in PFO Closure Hits New Milestone
FRANKFURT, GERMANY and MILAN, ITALY and ROME, ITALY and ALMATY, KAZAKHSTAN--(Healthcare Sales & Marketing Network) - HeartStitch® Inc, continues to increase its presence in Interventional Cardiology with continued successful cases worldwide. These rece... Devices, Interventional, Cardiology HeartStitch, NobleStitch, patent foramen ovale, PFO closure (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - September 6, 2016 Category: Pharmaceuticals Source Type: news

Jul 29 Cardiology News Jul 29 Cardiology News
Potential underuse of cardiac tests in heart failure, an antidote for prolonged sitting, and a new practice advisory from the AAN on patent foramen ovale (PFO) closure and stroke. theheart.org on Medscape (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - July 29, 2016 Category: Consumer Health News Tags: Cardiology News Source Type: news

AAN recommends against routine closure of patent foramen ovale for secondary stroke prevention
An updated practice advisory from the American Academy of Neurology does not recommend the routine use of catheter-based closure of patent foramen ovale in patients with a history of cryptogenic... (Source: Clinical Neurology News)
Source: Clinical Neurology News - July 27, 2016 Category: Neurology Source Type: news

AAN recommends against routine closure of patent foramen ovale for secondary stroke prevention
An updated practice advisory from the American Academy of Neurology does not recommend the routine use of catheter-based closure of patent foramen ovale in patients with a history of cryptogenic... (Source: Family Practice News)
Source: Family Practice News - July 27, 2016 Category: Primary Care Source Type: news

HeartStitch(R) Announces Top New Sales and Marketing VP Joins the HeartStitch Team
Highly Experienced Executive Will Fill Important Role of Vice President, International Sales and Marketing LOS ANGELES, CA--(Healthcare Sales & Marketing Network) - HeartStitch® is pleased to announce the appointment of Dirk Segers as Vice President... Devices, Interventional, Cardiology, PersonnelHeartStitch, patent foramen ovale, PFO Closure (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - June 10, 2016 Category: Pharmaceuticals Source Type: news

MassDevice.com +5 | The top 5 medtech stories for May 26, 2016
Say hello to MassDevice +5, a bite-sized view of the top five medtech stories of the day. This feature of MassDevice.com’s coverage highlights our 5 biggest and most influential stories from the day’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry. Get this in your inbox everyday by subscribing to our newsletters.   5. Ortho Kinematics wins Health Canada nod for VMA system Ortho Kinematics said today it won Health Canada authorization for its Vertebral Motion Analysis spinal imaging system. The VMA system from Austin, Texas-based Ortho Kinema...
Source: Mass Device - May 26, 2016 Category: Medical Equipment Authors: MassDevice Tags: Blog Plus 5 Source Type: news

FDA panel backs St. Jude’s Amplatzer stroke device in 15-1 vote
An FDA panel Tuesday voted 15-1 in support of St. Jude Medical‘s (NYSE:STJ) Amplatzer cardiac implant for treating patent foramen ovale, according to the Minneapolis Star Tribune. The Amplatzer PFO device is a nitinol and polyester mesh “double disc” that’s designed to close a naturally occurring hole in the heart that poses the risk of thrombosis and stroke. The panel found in favor of the device, saying that a long-running study of it showed a “reasonable assurance” that it was safe for use, according to the paper. In a closer vote, the same panel ruled 11-5 that the device’...
Source: Mass Device - May 26, 2016 Category: Medical Equipment Authors: Fink Densford Tags: Cardiac Implants Cardiovascular Food & Drug Administration (FDA) St. Jude Medical Source Type: news

FDA Panel Votes 15-1 To Approve St. Jude's Stroke Prevention Device
An FDA panel has issued the green light for St. Jude’s Aplatzer PFO Occluder device, saying studies of the device showed “reasonable assurance” that the device was safe for use. The implant, which is intended to prevent recurrent ischemic strokes in patients with patent foramen ovale (PFO), has been the subject of controversy for decades, and the panel’s decision represents a major milestone for the technology, said St. Jude executives. (Source: Medical Design Online News)
Source: Medical Design Online News - May 26, 2016 Category: Medical Equipment Source Type: news

MassDevice.com +5 | The top 5 medtech stories for April 13, 2016
Say hello to MassDevice +5, a bite-sized view of the top five medtech stories of the day. This feature of MassDevice.com’s coverage highlights our 5 biggest and most influential stories from the day’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry. Get this in your inbox everyday by subscribing to our newsletters.   5. Toshiba partners with UCI to study potential brain damage in HS football players Toshiba said yesterday it is partnering with the University of California, Irvine to study possible brain damage incurred in high school football ...
Source: Mass Device - April 13, 2016 Category: Medical Equipment Authors: MassDevice Tags: News Well Plus 5 Source Type: news

FDA panel to mull St. Jude Medical’s Amplatzer PFO occluder cardiac implant
An FDA advisory panel is slated to review the clinical data behind St. Jude Medical‘s (NYSE:STJ) bid for pre-market approval of its Amplatzer cardiac implant for treating patent foramen ovale. The FDA’s Circulatory System Devices Panel is due to convene May 24 for a hearing on the Amplatzer PFO device,  a nitinol and polyester mesh “double disc” that’s designed to close a naturally occurring hole in the heart that poses the risk of thrombosis and stroke. Back in October 2012, the Amplatzer PFO device failed to meet the primary endpoint in a 980-patient clinical trial c...
Source: Mass Device - April 13, 2016 Category: Medical Equipment Authors: Brad Perriello Tags: Cardiac Implants Clinical Trials Food & Drug Administration (FDA) St. Jude Medical Source Type: news

Structural heart: Nobles Medical, HeartStitch tout cardiac suture procedures
Structural heart focused HeartStitch and Nobles Medical today touted separate procedures utilizing cardiac sutures with the company’s Hearstitch ST and Noblestitch EL devices. Nobles Medical Tech said that the NobleStitch EL device was used in the 1st percutaneous ASD closure and ASA repair and remodeling without the use of an implantable device. The NobleStitch EL device closes the hole through a minimally invasive cardiovascular suturing procedure, the company said, with a routine cardiac catheterization procedure to secure the closure. “This was the 1st time we used the NobleStitch cardiovascular suturi...
Source: Mass Device - March 10, 2016 Category: Medical Equipment Authors: Fink Densford Tags: Cardiac Implants Cardiovascular Clinical Trials HeartStitch Nobles Medical Technology Source Type: news

Closure May Prevent Further Patent Foramen Ovale-Related Strokes (CME/CE)
(MedPage Today) -- Analysis of RESPECT trial suggests fewer PFO-related second strokes with device closure (Source: MedPage Today Cardiovascular)
Source: MedPage Today Cardiovascular - February 18, 2016 Category: Cardiology Source Type: news

ISC: Closure May Prevent Further Patent Foramen Ovale-Related Strokes (CME/CE)
(MedPage Today) -- Analysis of RESPECT trial suggests fewer PFO-related second strokes with device closure (Source: MedPage Today Meeting Coverage)
Source: MedPage Today Meeting Coverage - February 18, 2016 Category: Journals (General) Source Type: news

This month’s most missed USMLE question--and the right answer
As you prepare for the United States Medical Licensing Exam® (USMLE®), do you know which questions to look out for? We’re giving you an exclusive scoop on the most challenging USMLE test prep questions and expert strategies to help you beat them. Find out what this month’s toughest question is and receive an expert video explanation of the answer from Kaplan Medical. Welcome to the third post in AMA Wire’s® series, “Tutor talk: Tips from Kaplan Medical on the most missed USMLE test prep questions.” Each month, we’re revealing one of the top questions stu...
Source: AMA Wire - November 25, 2015 Category: Journals (General) Authors: Troy Parks Source Type: news

HeartStitch touts new PFO closure method
Structural heart focused HeartStitch said today its NobleStitch EL device was used to repair 3 patients with patent forman ovale heart defects in Astana, Kazakhstan. A patent foramen ovale is a congenital heart disease in which hole in the heart that normally seals at birth remains open, and can lead to severe migraines, visual auras and stroke, the company said. The procedures were performed by Dr. Michael Mullen and guided by Anthony Nobles at the National Research Cardiac Surgery Center in Astana, according to the company. “We are gratified that our colleagues from abroad have brought this technology to Kazakhstan...
Source: Mass Device - September 11, 2015 Category: Medical Equipment Authors: Fink Densford Tags: Cardiac Implants Cardiovascular HeartStitch Source Type: news

"I Had A Stroke at 38 Years Old"
How one woman turned a life-changing event into an opportunity to thrive. As told to Kristin Canning By Kristin Canning, SELF (Photo: Courtesy of Merideth Gilmor) I wasn't supposed to have a stroke. I was 38 years old, a mom in "perfect" health. I run my own pro-athlete public relations firm, so I have to stay on pace with the likes of Maria Sharapova, Cam Newton and Colin Kaepernick. I was under stress, sure, but I was happy, enjoying my crazy, packed days. It happened about a year ago. One of my best friends was getting married in the Berkshire Mountains, so I flew from Charlotte, North Carolina, where I'd bee...
Source: Healthy Living - The Huffington Post - August 26, 2015 Category: Consumer Health News Source Type: news

Minor heart feature may mean trouble at high altitude
A common heart feature long thought to have negligible effects on human health and performance may be problematic at high altitude. That's a key finding from a study that looked at the effects of a condition known as patent foramen ovale in a high-altitude Bolivian setting. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - June 30, 2015 Category: Science Source Type: news

Oregon study: Minor heart feature may mean trouble at high altitude
(University of Oregon) A common heart feature long thought to have negligible effects on human health and performance may be problematic at high altitude. That's a key finding from a University of Oregon study that looked at the effects of a condition known as patent foramen ovale in a high-altitude Bolivian setting. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - June 30, 2015 Category: Global & Universal Source Type: news

Another PFO Closure Study Yields Mixed Migraine Results Another PFO Closure Study Yields Mixed Migraine Results
The latest trial to investigate patent foramen ovale closure as potential treatment for refractory migraine has again yielded overall negative results but suggests possible benefit for those with aura. Medscape Medical News (Source: Medscape Neurology and Neurosurgery Headlines)
Source: Medscape Neurology and Neurosurgery Headlines - June 26, 2015 Category: Neurology Tags: Neurology & Neurosurgery News Source Type: news

“I’m Just In the Band”
Discussion Instrumental music, either as an avocation or profession, provides great pleasure for those performing and listening. Unfortunately it can also cause health problems. Many of the problems are musculoskeletal or neurological in etiology due to overuse and the musician may experience pain. Prelude to pain can include stiffness or tingling or other skin sensations. Musicians may experience weakness, loss of function, control (accuracy) and ability (speed) as well as problems with tone. “The most prevent problems involve overuse of muscles resulting from repetitive movements of playing, often in combination w...
Source: PediatricEducation.org - November 17, 2014 Category: Pediatrics Authors: pediatriceducationmin Tags: Uncategorized Source Type: news

Key Blood Chemistry Changes Seen After PFO Closure Key Blood Chemistry Changes Seen After PFO Closure
The findings suggest there's more to the risk for stroke associated with patent foramen ovale than simply allowing clots to pass to the brain. Medscape Medical News (Source: Medscape Neurology and Neurosurgery Headlines)
Source: Medscape Neurology and Neurosurgery Headlines - October 29, 2014 Category: Neurology Tags: Neurology & Neurosurgery News Source Type: news

Stroke Rounds: Best PFO Diagnostic With Lung Clots?
(MedPage Today) -- Is there a best way to find patent foramen ovale (PFO)? (Source: MedPage Today Cardiovascular)
Source: MedPage Today Cardiovascular - October 16, 2014 Category: Cardiology Source Type: news

TCT: PFO No Panacea for Migraine
WASHINGTON (MedPage Today) -- Percutaneous patent foramen ovale (PFO) closure did not significantly reduce the number of monthly migraine days compared with medical treatment, researchers reported here. (Source: MedPage Today Cardiovascular)
Source: MedPage Today Cardiovascular - September 17, 2014 Category: Cardiology Source Type: news

Transcranial Ultrasonography for PFO Screening?Transcranial Ultrasonography for PFO Screening?
Is non-invasive transcranial doppler a feasible alternative to more invasive and more costly transesophageal echocardiography for the detection of patent foramen ovale? Cardiovascular Ultrasound (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - July 21, 2014 Category: Consumer Health News Tags: Radiology Journal Article Source Type: news

Cardio Notes: Analysis Knocks PFO Closure
(MedPage Today) -- A meta-analysis confirms a previous one that found no benefit to patent foramen ovale closure versus medical therapy. Also, an ultrasound contrast agent is cleared of pulmonary hemodynamic effects. (Source: MedPage Today Cardiovascular)
Source: MedPage Today Cardiovascular - September 23, 2013 Category: Cardiology Source Type: news

Mixed Results for PFO Closure in Meta-Analysis (CME/CE)
(MedPage Today) -- Using a device for patent foramen ovale closure did not reduce recurrent events in patients with cryptogenic ischemic stroke, although there was a hint of benefit, a meta-analysis showed. (Source: MedPage Today Cardiovascular)
Source: MedPage Today Cardiovascular - August 20, 2013 Category: Cardiology Source Type: news

Patent Foramen Ovale Benefits From Transcatheter ClosurePatent Foramen Ovale Benefits From Transcatheter Closure
Transcatheter closure of patent foramen ovale (PFO) is superior to medical management for preventing recurrent vascular events, but not all closure devices are equal. Reuters Health Information (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - July 17, 2013 Category: Consumer Health News Tags: Cardiology News Source Type: news

Percutaneous Patent Foramen Ovale Closure Impact on MigrainePercutaneous Patent Foramen Ovale Closure Impact on Migraine
Will randomized studies of patent foramen ovale closure in deep sea divers and others show reduction in migraine headaches, or is a turbo-placebo-effect taking place? Interventional Cardiology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - June 28, 2013 Category: Consumer Health News Tags: Cardiology Journal Article Source Type: news

RESPECT "device-in-place" analysis: Benefits of PFO closure?
A new post hoc "device-in-place" analysis of the RESPECT trial of patent foramen ovale closure in secondary stroke prevention has shown a magnification of benefits in comparison with the intention-to-treat or per-protocol analyses presented previously. (Source: theHeart.org)
Source: theHeart.org - June 26, 2013 Category: Cardiology Source Type: news

RESPECT 'Device in Place' Analysis: Benefits of PFO Closure?RESPECT 'Device in Place' Analysis: Benefits of PFO Closure?
A new post hoc 'device in place' analysis of the RESPECT trial of patent foramen ovale closure in secondary stroke prevention has shown a magnification of benefits compared with the intention-to-treat or per-protocol analyses presented previously. Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - June 26, 2013 Category: Consumer Health News Tags: Neurology & Neurosurgery News Source Type: news

Heart Defect Closure Rate Increasing (CME/CE)
ORLANDO (MedPage Today) -- The number of procedures performed to close an atrial septal defect or patent foramen ovale has increased in recent years, while length of stay associated with the procedure has dropped, researchers found. (Source: MedPage Today Cardiovascular)
Source: MedPage Today Cardiovascular - May 9, 2013 Category: Cardiology Source Type: news

PFO Stroke Risk May Be Overstated (CME/CE)
(MedPage Today) -- Among healthy older adults who were followed for more than a decade, the presence of a patent foramen ovale (PFO) was not associated with ischemic stroke or subclinical cerebrovascular disease, researchers found. (Source: MedPage Today Cardiovascular)
Source: MedPage Today Cardiovascular - April 30, 2013 Category: Cardiology Source Type: news

Patent foramen ovale closure debate still smolders
Two randomized controlled trials in The New England Journal of Medicine fail to prove that closing a patent foramen ovale can reduce risk for recurrent cryptogenic stroke. (Source: MedWire News - Cardiology)
Source: MedWire News - Cardiology - March 25, 2013 Category: Cardiology Source Type: news

The Best Option for Preventing Cryptogenic Embolism
(Ivanhoe Newswire) -- Past studies have shown an association of cryptogenic stroke and embolism with patent foramen ovale (PFO). However, the question of how to prevent it in patients remains unanswered. Now, recent research is investigating whether percutaneous closure or antithrombotic medications are superior. (Source: Medical Headlines From Ivanhoe.com)
Source: Medical Headlines From Ivanhoe.com - March 25, 2013 Category: Consumer Health News Source Type: news

PFO Closure Still an Open Question (CME/CE)
(MedPage Today) -- The negative results of three randomized trials should have closed the book on patent foramen ovale closure in cryptogenic stroke, but the book is still being read. (Source: MedPage Today Cardiovascular)
Source: MedPage Today Cardiovascular - March 20, 2013 Category: Cardiology Source Type: news

RESPECT and PC Trial published: Results of PFO closure debated again
The randomized, controlled clinical trials both missed their primary end points, findings that disappointed many hoping that closure of patent foramen ovale with the Amplatzer occluder would prevent stroke recurrence in patients who previously had a cryptogenic stroke. The results, however, are still being debated among those in the clinical community. (Source: theHeart.org)
Source: theHeart.org - March 20, 2013 Category: Cardiology Source Type: news

Data from St. Jude Medical RESPECT Trial for PFO Closure Highlighted at International Stroke Conference 2013
Presentation of neurological data confirms patients in the device group had fewer, smaller strokes that were less likely to originate from blood clots passing through the PFO ST. PAUL, Minn.--(Healthcare Sales & Marketing Network)--St. Jude Medical, Inc... Devices, Interventional CardiologySt. Jude Medical, patent foramen ovale, AMPLATZER, AMPLATZER PFO Occluder (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - February 8, 2013 Category: Pharmaceuticals Source Type: news

The RESPECT TrialThe RESPECT Trial
What are the pros and cons of patent foramen ovale closure, when compared to medical management? The Journal of Invasive Cardiology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - January 28, 2013 Category: Consumer Health News Tags: Cardiology Journal Article Source Type: news

Patent Foramen Ovale and Paradoxical Stroke in a Young Cyclist
Most patients with PFO remain asymptomatic because under normal physiologic conditions, a small amount of left-to-right shunting occurs without causing significant hemodynamic change. Here, a case in point. (Source: Consultant Live)
Source: Consultant Live - January 25, 2013 Category: Primary Care Source Type: news